Selective Serotonin Reuptake Inhibitors: all 1,366 studies that test it

Page 5 of 14. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.

• The Role of GABA and Neurosteroids in Premenstrual Dysphoric DisorderCompletedNCT00678574Phase 4Results posted
• A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic DisorderCompletedNCT00677352Phase 4Results posted
• Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in WomenCompletedNCT00676026Not applicableResults posted
• Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive DisorderCompletedNCT00672958Phase 3Results posted
• Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive DisorderCompletedNCT00672620Phase 3Results posted
• Escitalopram in Adult Patients With Major Depressive DisorderCompletedNCT00668525Phase 3Results posted
• Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major DepressionCompletedNCT00655057Phase 2/3Results posted
• Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent HumansCompletedNCT00654953Phase 2Results posted
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)CompletedNCT00644358Phase 3Results posted
• A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With SchizophreniaCompletedNCT00640510Phase 3Results posted
• Escitalopram Treatment of Night Eating SyndromeCompletedNCT00636649Not applicableResults posted
• Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive DisorderCompletedNCT00635219Phase 3Results posted
• Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.CompletedNCT00624013Phase 4Results posted
• Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive DisorderCompletedNCT00621946Phase 4Results posted
• Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, DepressedCompletedNCT00618748Phase 3Results posted
• Effect of Antidepressants on Sex Hormone Levels and Sexual FunctioningCompletedNCT00611975Phase 4Results posted
• PET Imaging Study of Recovered AnorexicsCompletedNCT00603018Not applicableResults posted
• Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum DepressionCompletedNCT00602355Phase 2Results posted
• Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With DepressionCompletedNCT00602290Phase 4Results posted
• Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older AdultsCompletedNCT00601965Not applicableResults posted
• Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive EpisodesCompletedNCT00596817Phase 3Results posted
• Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar DisorderTerminatedNCT00592852Phase 4Results posted
• Combining Medications to Enhance Depression OutcomesCompletedNCT00590863Phase 4Results posted
• The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed PatientsCompletedNCT00581009Phase 1/2Results posted
• Sequential Use of Fluoxetine for Smokers With Elevated Depressive SymptomsCompletedNCT00578669Phase 3Results posted
• Responses of Myocardial Ischemia to Escitalopram TreatmentCompletedNCT00574847Phase 4Results posted
• Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With CitalopramCompletedNCT00562861Phase 2/3Results posted
• Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)CompletedNCT00560612Phase 4Results posted
• Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)TerminatedNCT00557622Phase 2Results posted
• Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric DisorderCompletedNCT00536198Phase 4Results posted
• Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving TreatmentCompletedNCT00536172Phase 4Results posted
• Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality DisorderCompletedNCT00533117Phase 4Results posted
• Early Detection and Intervention for the Prevention of PsychosisCompletedNCT00531518Not applicableResults posted
• Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot StudyTerminatedNCT00523705Phase 4Results posted
• Does Dual Therapy Hasten Antidepressant Response?CompletedNCT00519428Phase 4Results posted
• Glucose and Lipid Metabolism on Antipsychotic MedicationCompletedNCT00515723Not applicableResults posted
• Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With OlanzapineCompletedNCT00512070Not applicableResults posted
• Olanzapine Treatment of Patients With Bipolar I DisorderCompletedNCT00510146Phase 3Results posted
• Citalopram in Irritable Bowel SyndromeCompletedNCT00477165Phase 2Results posted
• SSRI and BuprenorphineCompletedNCT00475878Phase 3Results posted
• Brain GABA Levels and Treatment Response in Major Depressive DisorderCompletedNCT00464711Phase 4Results posted
• Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant TreatmentCompletedNCT00456014Not applicableResults posted
• Fluoxetine and Bupropion to Treat Patients With Depression and AlcoholismTerminatedNCT00449007Phase 4Results posted
• Diabetes in Neuropsychiatric DisordersCompletedNCT00446992Phase 1/2Results posted
• Paroxetine/Bupropion in Suicide Attempters/Ideators With Major DepressionTerminatedNCT00429169Phase 4Results posted
• MDD POC Study GSK372475 Subjects Depressive DiseaseCompletedNCT00420641Phase 2Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompletedNCT00406640Phase 3Results posted
• Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00404755Phase 4Results posted
• Monoamine Transporters Genotypes: Risk of PTSD and Related ComorbiditiesCompletedNCT00403455Phase 3Results posted
• A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar PatientsCompletedNCT00402324Phase 4Results posted
• Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress DisorderTerminatedNCT00391430Phase 4Results posted
• Medication, Weight Gain and GI HormonesCompletedNCT00384332Phase 4Results posted
• Sertraline Pharmacotherapy for Alcoholism SubtypesCompletedNCT00368550Phase 4Results posted
• Imaging Predictors of Treatment Response in DepressionCompletedNCT00367341Not applicableResults posted
• Identifying Factors That Predict Antidepressant Treatment ResponseCompletedNCT00360399Not applicableResults posted
• Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 TreatmentCompletedNCT00352885Phase 4Results posted
• Ziprasidone vs. Sertraline/Haloperidol in Psychotic DepressionCompletedNCT00340379Phase 2/3Results posted
• Treatment of Hypochondriasis With CBT and/or SSRICompletedNCT00339079Phase 1/2Results posted
• Naltrexone & SSRI in Alcoholics With Depression/PTSDCompletedNCT00338962Phase 3Results posted
• Efficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaCompletedNCT00337662Phase 4Results posted
• Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)CompletedNCT00303602Phase 4Results posted
• Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00296725Phase 1/2Results posted
• Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia NervosaCompletedNCT00288574Phase 4Results posted
• Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety DisorderCompletedNCT00282828Phase 4Results posted
• PET Imaging and Olanzapine Treatment in Borderline Personality DisorderCompletedNCT00275301Not applicableResults posted
• Citalopram to Enhance Cognition in HDCompletedNCT00271596Phase 2Results posted
• Combined Treatment for Alcohol-Dependent Individuals With PTSDCompletedNCT00262223Phase 2Results posted
• Olanzapine in the Treatment of Patients With Anorexia NervosaCompletedNCT00260962Phase 2Results posted
• Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With OlanzapineCompletedNCT00259272Phase 3Results posted
• Insomnia and Drug Relapse RiskCompletedNCT00253890Phase 3Results posted
• Functional Dyspepsia Treatment TrialCompletedNCT00248651Phase 2/3Results posted
• Paroxetine for Comorbid Social Anxiety Disorder and AlcoholismCompletedNCT00246441Phase 4Results posted
• Fluoxetine in Pediatric Body Dysmorphic DisorderCompletedNCT00245635Phase 4Results posted
• Magnetic Resonance Imaging Study of Geriatric DepressionCompletedNCT00245557Not applicableResults posted
• Treatment of Post-Traumatic Brain Injury (TBI) DepressionCompletedNCT00233103Phase 2Results posted
• Escitalopram in the Treatment of Dysthymic Disorder, Double BlindCompletedNCT00220701Phase 4Results posted
• Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)CompletedNCT00219349Phase 4Results posted
• Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1CompletedNCT00218439Not applicableResults posted
• Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8TerminatedNCT00218036Phase 2Results posted
• Pilot Study to Evaluate Escitalopram in Obsessive-compulsive DisorderCompletedNCT00215137Phase 2Results posted
• Depression-Diabetes Mechanisms: Urban African AmericansCompletedNCT00209170Phase 4Results posted
• Metabolic Effects of Antipsychotics in ChildrenCompletedNCT00205699Phase 4Results posted
• Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00190749Phase 4Results posted
• Short Term Rescue Study of OlanzapineCompletedNCT00186017Phase 4Results posted
• Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving EscitalopramCompletedNCT00183677Phase 4Results posted
• Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia PatientsCompletedNCT00183625Phase 4Results posted
• Early Intervention With Fluoxetine in AutismCompletedNCT00183339Phase 2Results posted
• A Study of Sertraline to Prevent PTSDCompletedNCT00182078Phase 4Results posted
• Characteristics of Sleep Patterns in Young Adults With and Without InsomniaCompletedNCT00177216Phase 4Results posted
• Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C PatientsCompletedNCT00166296Phase 2Results posted
• Depression, Epinephrine, and Platelet FunctionCompletedNCT00166114Phase 4Results posted
• Treatments for Psychogenic Nonepileptic Seizures (NES)CompletedNCT00159965Phase 4Results posted
• Effectiveness of Escitalopram in the Treatment of Body Dysmorphic DisorderCompletedNCT00149799Phase 3Results posted
• Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana DependenceCompletedNCT00149643Phase 2Results posted
• Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected PatientsCompletedNCT00136318Phase 3Results posted
• Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I DisorderCompletedNCT00129220Phase 3Results posted
• Comparison of Two Treatments for Post-Traumatic Stress DisorderCompletedNCT00127673Phase 3Results posted
• Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk FactorsCompletedNCT00116857Phase 3Results posted
• Safety and Efficacy of Fluoxetine in Juvenile FibromyalgiaCompletedNCT00115804Phase 3Results posted
• The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive DisorderCompletedNCT00107120Phase 3Results posted

← Selective Serotonin Reuptake Inhibitors overview